Elicio Therapeutics, Inc. (NASDAQ: ELTX)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 2.71 (-0.05 / -1.81%) | 2.76 (-1.32 / -32.35%) | 2.73 (-0.03 / -1.09%) |
| 17-Jun 07:34 | 16-Jun 16:00 | 16-Jun 19:04 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 4.08 | Year Low | 2.66 |
| Open | 4.06 | Year High | 16.00 |
| Day Low | 2.66 | Price Avg 50 | 11.24 |
| Day High | 4.08 | Price Avg 200 | 10.04 |
| Volume | 4.78 M | Market Cap | 52.68 M |
News
| Symbol | Catalyst News |
|---|---|
| ELTX | Elicio Therapeutics Pancreatic Cancer Study Disappoints Benzinga | 2026-06-15 12:29:22 Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal Reuters | 2026-06-15 09:58:37 Elicio Therapeutics, Inc. ($ELTX) shares are sliding ahead of the open Catalyst picR | 2026-06-15 08:05:00 Elicio Therapeutics ($ELTX) Phase 2 Study Misses Primary Endpoint Catalyst picR | 2026-06-15 07:44:54 Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out Seeking Alpha | 2026-04-29 05:51:08 |
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| ELTX | -32.35 | -80.75 | -74.04 | -77.30 | -66.13 | -64.20 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/11/2026 | AMC | ELTX | Elicio Therapeutics | Q1 2026 | EPS | -0.47 | -0.65 | -38.30 | -0.87 | 25.30 | |
| 05/11/2026 | AMC | ELTX | Elicio Therapeutics | Q1 2026 | REV | ||||||
| 03/12/2026 | AMC | ELTX | Elicio Therapeutics | Q4 2025 | EPS | -0.47 | -0.45 | 4.26 | -1.02 | 55.90 | |
| 03/12/2026 | AMC | ELTX | Elicio Therapeutics | Q4 2025 | REV | ||||||
| 11/13/2025 | AMC | ELTX | Elicio Therapeutics | Q3 2025 | EPS | -0.55 | -0.60 | -9.09 | -1.39 | 56.80 | |
| 11/13/2025 | AMC | ELTX | Elicio Therapeutics | Q3 2025 | REV | ||||||
| 08/07/2025 | AMC | ELTX | Elicio Therapeutics | Q2 2025 | EPS | -0.65 | -0.66 | -1.54 | -0.64 | -3.10 | |
| 08/07/2025 | AMC | ELTX | Elicio Therapeutics | Q2 2025 | REV | 0.00 | 0.00 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 03/13/2026 | ELTX | HC Wainwright & Co. | Buy | Buy | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
